Most P3 studies will report TLD between 6 and 12 weeks. The complete enrollment of 509 patients press release was June 08, 2021 - and it was probably released a week after the event. AD is not a one-year study, it's a 48-week study. So, allowing for a couple stragglers, LPLV was early May 2022. We are at 20 weeks now. Five months is plenty of time to get TLD analyzed. I think the likelihood of a mixed TLD release has become much higher and I sold 1/6 of my shares earlier this week and now have the lowest # of shares I've held since early 2018.
News 
Market Data 
Discover 
AI
